1. Home
  2. SION vs SHEN Comparison

SION vs SHEN Comparison

Compare SION & SHEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SION
  • SHEN
  • Stock Information
  • Founded
  • SION 2019
  • SHEN 1902
  • Country
  • SION United States
  • SHEN United States
  • Employees
  • SION N/A
  • SHEN N/A
  • Industry
  • SION
  • SHEN Telecommunications Equipment
  • Sector
  • SION
  • SHEN Telecommunications
  • Exchange
  • SION NYSE
  • SHEN Nasdaq
  • Market Cap
  • SION 564.4M
  • SHEN 673.1M
  • IPO Year
  • SION 2025
  • SHEN N/A
  • Fundamental
  • Price
  • SION $14.49
  • SHEN $13.91
  • Analyst Decision
  • SION Strong Buy
  • SHEN Strong Buy
  • Analyst Count
  • SION 1
  • SHEN 1
  • Target Price
  • SION $32.00
  • SHEN $26.00
  • AVG Volume (30 Days)
  • SION 124.0K
  • SHEN 290.9K
  • Earning Date
  • SION 05-12-2025
  • SHEN 08-06-2025
  • Dividend Yield
  • SION N/A
  • SHEN 0.72%
  • EPS Growth
  • SION N/A
  • SHEN N/A
  • EPS
  • SION N/A
  • SHEN N/A
  • Revenue
  • SION N/A
  • SHEN $346,708,000.00
  • Revenue This Year
  • SION N/A
  • SHEN $13.32
  • Revenue Next Year
  • SION N/A
  • SHEN $7.77
  • P/E Ratio
  • SION N/A
  • SHEN N/A
  • Revenue Growth
  • SION N/A
  • SHEN 27.84
  • 52 Week Low
  • SION $7.26
  • SHEN $9.77
  • 52 Week High
  • SION $25.19
  • SHEN $21.89
  • Technical
  • Relative Strength Index (RSI)
  • SION N/A
  • SHEN 62.24
  • Support Level
  • SION N/A
  • SHEN $13.78
  • Resistance Level
  • SION N/A
  • SHEN $14.39
  • Average True Range (ATR)
  • SION 0.00
  • SHEN 0.40
  • MACD
  • SION 0.00
  • SHEN 0.08
  • Stochastic Oscillator
  • SION 0.00
  • SHEN 72.77

About SION SIONNA THERAPEUTICS INC

Sionna Therapeutics Inc is a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) patients by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein to deliver clinically meaningful benefit to CF patients. CF is a progressive and life-threatening genetic disease caused by inherited mutations in the CFTR gene, which heads to insufficient CFTR function. The Company is managed as one operating segment focused on the research and development of cystic fibrosis therapies.

About SHEN Shenandoah Telecommunications Co

Shenandoah Telecommunications Company, with its subsidiaries, provides various broadband communication products and services via its wireless, cable, fiber optic, and fixed wireless networks to customers in the Mid-Atlantic United States. The company operates through one business unit: Broadband. The broadband segment provides broadband Internet, video, and voice services to residential and commercial customers. The broadband segment generates the vast majority of the company's revenue, with the bulk of sales flowing from residential and small, and medium businesses within the broadband unit.

Share on Social Networks: